Related Experiment Videos

Protecting RNs from a possible return of SARS: is your facility ready?

New Jersey Nurse

|April 7, 2004

Summary

No abstract available in PubMed .

Related Concept Videos

Articles linked to this work by shared authors, journal, and citation graph.

Safety and efficacy of filgotinib in Japanese patients with rheumatoid arthritis: Week 156 interim results in FINCH 4.

Modern rheumatology·2024

Long-term safety and efficacy of filgotinib treatment for rheumatoid arthritis in Japanese patients naïve to MTX treatment (FINCH 3).

Modern rheumatology·2022

Safety and efficacy of filgotinib for Japanese patients with RA and inadequate response to MTX: FINCH 1 52-week results and FINCH 4 48-week results.

Modern rheumatology·2022

Olokizumab, a monoclonal antibody against interleukin 6, in combination with methotrexate in patients with rheumatoid arthritis inadequately controlled by methotrexate: efficacy and safety results of a randomised controlled phase III study.

Annals of the rheumatic diseases·2021

2021 American College of Rheumatology Guideline for the Treatment of Rheumatoid Arthritis.

Arthritis care & research·2021

2021 American College of Rheumatology Guideline for the Treatment of Rheumatoid Arthritis.

Arthritis & rheumatology (Hoboken, N.J.)·2021

See all related articles